Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
633 studies found for:    lupus
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed
Has Results
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Interventions: Drug: abatacept;   Drug: cyclophosphamide;   Drug: azathioprine;   Drug: prednisone;   Drug: abatacept placebo;   Drug: azathioprine placebo
2 Completed Transcultural Validation in French of the Systemic Lupus Activity Questionnaire (SLAQ) and the Lupus Quality Of Life (LupusQoL) Questionnaire
Condition: Lupus
Interventions: Other: SLA Questionnaire;   Other: Lupus Qol Questionnaire
3 Terminated
Has Results
Etanercept for the Treatment of Lupus Nephritis
Condition: Lupus Nephritis
Interventions: Drug: Etanercept;   Drug: Lupus Treatment- Standard of Care;   Drug: Placebo
4 Completed Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis
Conditions: SLE;   Lupus Nephritis;   Renal Insufficiency;   End-stage Renal Disease
Interventions: Drug: Tacrolimus;   Drug: cyclophosphamide
5 Completed CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE)
Condition: Systemic Lupus Erythematosus
6 Completed A Non-drug Study Profiling Cutaneous Lupus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic;   Lupus Erythematosus, Discoid
Interventions: Procedure: No intervention, skin biopsy;   Procedure: No intervention, blood collection;   Procedure: No intervention, urine collection
7 Completed Functional MRI in Lupus Nephritis
Conditions: Healthy;   Lupus Nephritis
8 Completed A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus
Conditions: Metabolic Syndrome;   Cardiovascular Risk Factors;   Systemic Lupus Erythematosus
9 Terminated Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus
Conditions: Cutaneous Lupus;   Discoid Lupus;   Lupus;   Systemic Lupus Erythematosus
Interventions: Drug: AMG811;   Drug: AMG811 Placebo
10 Completed Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
Condition: Lupus Nephritis
11 Recruiting Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Chronic Cutaneous
Intervention: Drug: Etanercept
12 Completed Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus
Condition: Discoid Lupus Erythematosus
Interventions: Drug: Pimecrolimus 1% cream;   Drug: betamethasone valerate 0.1% cream
13 Recruiting The Effect of Metformin on Reducing Lupus Flares
Condition: Systemic Lupus Erythematosus
Interventions: Drug: metformin;   Drug: placebo
14 Completed Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus
Condition: Subacute Cutaneous Lupus Erythematosus
Interventions: Drug: KRP203 - 1.2mg;   Drug: Placebo to KRP203 - 1.2 mg
15 Completed
Has Results
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab 300 mg;   Biological: Anifrolumab 1000 mg;   Other: Placebo
16 Completed
Has Results
IVIg Efficacy Study to Treat Cutaneous Lupus Erythematosus
Condition: Cutaneous Lupus Erythematosus
Intervention: Drug: IVIg
17 Completed Anti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: Rituximab
18 Completed Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors
Condition: Systemic Lupus Erythematosus
Intervention: Drug: atorvastatin
19 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: Cyclophosphamide
20 Recruiting Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus
Condition: Systemic Lupus Erythematosus
Intervention: Other: therapeutic education

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years